U.S. court rules in favor of Mylan over Biogen's key MS drug patent

A U.S. district court on Thursday ruled in favor of generic drugmaker Mylan NV in a patent dispute over Biogen Inc's blockbuster multiple sclerosis drug, Tecfidera, sending Biogen's shares down nearly 6%. [Source]

Origin: reuters.com

Category: healthNews

Topics: patent, Biogen's, Mylan, favor, court, nearly, shares, sending, Tecfidera, sclerosis, multiple, blockbuster, Inc's, Biogen, dispute, drugmaker, generic, ruled, district, rules

Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/Y3kfcCqEzlU/u-s-court-rules-in-favor-of-mylan-over-biogens-key-ms-drug-patent-idUSKBN23P2EY